4//SEC Filing
Kariv Tomer 4
Accession 0001104659-23-008599
CIK 0001035354other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:08 PM ET
Size
6.3 KB
Accession
0001104659-23-008599
Insider Transaction Report
Form 4
Kariv Tomer
Director
Transactions
- Award
Stock Options (Right to Buy)
2023-01-30+2,859→ 2,859 totalExercise: $4.00Exp: 2033-01-30→ Common Stock (2,859 underlying)
Footnotes (2)
- [F1]The stock option vests as to 50% of the underlying shares on the first anniversary of January 30, 2023, and the remaining 50% of the underlying shares will vest in twelve (12) equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date.
- [F2]The Reporting Person will assign the economic interests of this grant to the Pontifax funds, where he serves as a director of the General Partner.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001568077
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 4:08 PM ET
- Size
- 6.3 KB